Syndromic Testing

Sensitive, fully automated syndromic testing solutions, optimized for efficient, high-quality care.

patient and lab technician mosaic patient and lab technician mosaic

Rethinking Right

Right for all patients is not the same as right for each patient. Crafting a plan for the highest quality care is nothing if you can’t execute it. Hologic® syndromic testing assays and the Panther® System are the products of thoughtful design, optimizing the diagnostic process to deliver the best results rapidly and responsibly.

Image of a child resting at a hospital bed while holding a teddy bear toy

Just Right

When providers confront non-specific symptoms, molecular testing can help clarify critical care decisions with diagnostic insight. 

While traditional testing methods can be costly, cumbersome and consume precious time, comprehensive, one-size-fits-all solutions often use unnecessary resources.

The right path for each case is not the right path for every case.

Choosing Hologic helps give you the choice of how to treat each patient. Hologic syndromic testing empowers diagnostic stewardship: the thoughtful application of resources on a case-by-case basis.

Benefits of Syndromic Testing

Insightful Assays

Accurate, sensitive Hologic® Assays provide insight for care decisions.1-7

Swift Results

Rapid results can improve patient outcomes.8

Efficient Testing

Flexible, “just-right” testing minimizes healthcare expenditures.9

Old male patient meeting with a physician

The Right Patient

Laboratory tests are the foundation of our healthcare system. Providers rely on insights from lab tests to make critical care decisions. Hologic® syndromic tests are optimized to deliver high-quality results rapidly for every patient and tailored to each patient. No matter the volume of your lab, every sample represents the most important patient.

The Right Test

We honor Hologic’s legacy of diagnostic excellence and culture of innovation through our continuing commitment to delivering the sensitivity and specificity providers rely on with high-throughput automation. Discover the tools for diagnostic stewardship.

Lab technician inspecting vials

Panther Fusion® Assays

Harnessing the power of real-time PCR, Panther Fusion assays deliver highly sensitive results rapidly and efficiently through the power of Panther® Scalable Solutions.1-7

Random Access

The right test doesn’t mean every test. Run single tests as efficiently as large batches.

Rigorous Design

We take our time to ensure that every test on the market has enduring value and high-quality performance.

Wide Scope, Clear Vision

With up to 32 assay reagent kits on board, enhance your lab’s diagnostic potential.13

Optimize
Care

Thoughtful application of lab resources helps you deliver more results, more efficiently.9

Respiratory Portfolio

Equip your lab to detect a wide range of respiratory illnesses. Highly sensitive tests deliver the insight providers need to diagnose and treat respiratory infections.

Panther Fusion® SARS-CoV-2/Flu A/B/RSV Assay

Prepare your lab to help manage seasonal respiratory illnesses efficiently and effectively. Optimized to employ your lab’s resources responsibly and designed to provide comprehensive strain coverage, the Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay equips your lab to support seasonal respiratory care.1

Assay box on table in lab setting.

Panther Fusion® Flu A/B/RSV Assay

Equipping your lab to distinguish between common respiratory viruses empowers you to deliver clinicians the insight they need. The fully automated Panther Fusion system enables you to rapidly detect and differentiate influenza A (Flu A), influenza B (Flu B), and respiratory syncytial virus (RSV), supporting interventions for pediatric, elderly and immunocompromised populations.2,14

Assay box on table in lab setting

Panther Fusion® AdV/hMPV/RV Assay

The common cold, pneumonia, bronchitis, croup and other respiratory illnesses may be caused by Adenoviruses (AdV), human Metapneumovirus (hMPV), or rhinoviruses (RV).15-17 Rapid detection and differentiation of AdV, hMPV and RV infections empowers your lab to support timely diagnoses and treatment decisions.3,15-17

Assay box on table in lab setting

Panther Fusion® Paraflu Assay

Up to four types of human parainfluenza viruses (HPIVs) can circulate in any given year.18 With symptoms ranging from the common cold and croup to bronchitis and pneumonia, rapid detection and differentiation of HPIV-1, HPIV-2, HPIV-3, and HPIV-4 can help inform clinical care decisions.4,18 Leverage the full automation of Panther Fusion to deliver diagnostic insight.

Assay box on table in lab setting.

Aptima® SARS-CoV-2 Assay

SARS-CoV-2 infections can surge both during and outside of respiratory season.19 Hologic provides a scalable, fully automated platform for SARS-CoV-2 testing with a complimentary broad respiratory menu. The Aptima SARS-CoV-2 assay allows labs to meet testing demands with high-throughput standalone SARS testing with random and continuous access.5

Assay box on table in lab setting

GI Portfolio

Panther Fusion® GI Bacterial Assay

Detect the most common bacterial causes of acute diarrhea with the Panther Fusion GI Bacterial Assay. This multiplex real-time PCR assay delivers rapid detection of Salmonella, Shigella Campylobacter, and Shiga toxin 1/2.6

Assay box sitting on table with white background

Panther Fusion® GI Expanded Bacterial Assay

Expand your diagnostic insights with the Panther Fusion GI Expanded Bacterial Assay. This assay increases your menu of bacterial pathogens beyond the most common targets to include Plesiomonas, Vibrio, O157, and Yersinia.7

Assay box on table with white background

Innovation never rests, and neither do we.

Our GI portfolio is under development to bring the diagnostic power of Hologic to a wide range of gastrointestinal illnesses.

Panther Fusion® GI Viral Assay*

  • Norovirus
  • Adenovirus
  • Rotavirus
  • Sapovirus/Astrovirus

Panther Fusion® GI Parasite Assay*

  • Giardia lamblia
  • Cryptosporidium spp.
  • Entamoeba histolytica
  • Cyclospora cayetanensis

Panther Fusion® GI C. difficile Assay*

  • Toxigenic C. difficile
  • Toxigenic hypervirulent C. difficile PCR ribotype 027 (NAP1/B1/027)

* In development and not for sale

A Family of Tests

Hologic syndromic assays are part of our broad suite of assays. All assays are designed to run on Panther® Scalable Solutions delivering efficiency and accuracy.

Group of assay box image all together

The Right Time

In high-quality care, time is of the essence. Fully automated, high-throughput diagnostic solutions let your lab do more with the staff you have today. Seize the power of the Panther System to deliver for more patients.

Lab technician standing in front of the Panther Fusion machine

Panther Scalable Solutions

With real-time PCR, TMA and RT-TMA assays on a single, fully automated platform, Panther Scalable Solutions empowers your lab to deliver results with seamless efficiency.

Labor Savings

Reduce manual steps and increase walkaway time with high-throughput automation.20

Cost Savings

Consolidate your supply and regulate overhead while delivering the most results per square foot.20

Time Savings

Streamline lab operations and optimize diagnostic procedures to get the right results to providers rapidly.20

Scaled to Your Lab

Built for efficiency and designed to grow with your lab, Panther Scalable Solutions is the right fit.20

Collection Devices

Hologic's innovations for efficiency extend beyond the lab. Our full suite of intuitively designed collection devices help streamline the diagnostic process from collection to results.

Collection devices
† In Development and not for sale
    1. Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay. US package insert AW-32326-001. Hologic, Inc.; 2025. 2. Panther Fusion Flu A/B/RSV Assay. US package insert AW-16832. Hologic, Inc.; 2019. 3. Panther Fusion AdV/hMPV/RV Assay. US package insert AW-28996-001. Hologic, Inc.; 2023 4. Panther Fusion Paraflu Assay. US package insert AW-16833. Hologic, Inc.; 2019. 5. Aptima SARS-CoV-2 Assay. US package insert AW-32532-001. San Diego, CA: Hologic, Inc; 2025. 6. Panther Fusion GI Bacterial Assay. US package insert AW-33557-001. Hologic, Inc.; 2025. 7. Panther Fusion GI Expanded Bacterial Assay. US package insert AW-33558-001. Hologic, Inc.; 2025. 8. Martinez RM, Kay HE, Scicchitano LM. Implementation of non-batched respiratory virus assay significantly impacts patient outcomes in the ICU. Poster presented at: Clinical Virology Symposium; May 19-22 2016; Daytona Beach, FL. 9. Shaik T, Mahmood R, Kanagala SG, et al. Lab testing overload: a comprehensive analysis of overutilization in hospital-based settings. Proc (Bayl Univ Med Cent). 2024 Feb 8;37(2):312-316. doi: 10.1080/08998280.2023.2288788. PMID: 38343466; PMCID: PMC10857549 10. Value of lab testing. American Clinical Laboratory Association. Accessed October 31, 2025. https://www.acla.com/value-of-lab-testing/ 11. U.S. molecular diagnostics market size, share report, 2030. Grand View Research. Accessed October 31, 2025. https://www.grandviewresearch.com/industry-analysis/us-molecular-diagnostics-market-report 12. van Houten CB, Cohen A, Engelhard D, et al. Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment). Eur J Clin Microbiol Infect Dis. 38, 505–514 (2019). https://doi.org/10.1007/s10096-018-03454-2 13. Panther/Panther Fusion System Operator’s Manual. AW-26055. 2022. 14. Berry GJ, Jhaveri TA, Larkin PMK, et al. ADLM guidance document on laboratory diagnosis of respiratory viruses. J Appl Lab Med. 2024 May 2;9(3):599-628. doi: 10.1093/jalm/jfae010. PMID: 38695489 15. CDC. Clinical overview of adenovirus. Centers for Disease Control and Prevention. June 4, 2024. Accessed October 31, 2025. https://www.cdc.gov/adenovirus/hcp/clinical-overview/index.html 16. CDC. About rhinoviruses. Centers for Disease Control and Prevention. April 24, 2024. Accessed October 31, 2025. https://www.cdc.gov/rhinoviruses/about/index.html 17.CDC. About human metapneumovirus. Centers for Disease Control and Prevention. April 11, 2024. Accessed October 31, 2025. https://www.cdc.gov/human-metapneumovirus/about/index.html 18. CDC. Clinical overview of human parainfluenza viruses (HPIVs). Centers for Disease Control and Prevention. June 5, 2024. Accessed October 31, 2025. https://www.cdc.gov/parainfluenza/hcp/clinical-overview/index.html 19. CDC. Trends in United States COVID-19 deaths, emergency department (ED) visits, and test positivity by geographic area. Centers for Disease Control and Prevention. Updated September 5, 2025. Accessed October 31, 2025. https://covid.cdc.gov/covid-data-tracker/#trends_select_testpositivity_00 20. Data on file.